The endothelin B (ETB) receptor agonist IRL 1620 is highly vasoconstrictive in two syngeneic rat tumour lines: potential for selective tumour blood flow modification

Cemazar, M., Wilson, I., Prise, V.E. et al. (3 more authors) (2005) The endothelin B (ETB) receptor agonist IRL 1620 is highly vasoconstrictive in two syngeneic rat tumour lines: potential for selective tumour blood flow modification. British Journal of Cancer , 93 (1). pp. 98-106. ISSN 0007-0920

Abstract

Metadata

Authors/Creators:
  • Cemazar, M.
  • Wilson, I.
  • Prise, V.E.
  • Bell, K.M.
  • Hill, S.A.
  • Tozer, G.M.
Copyright, Publisher and Additional Information: © 2005 Cancer Research UK. From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
Keywords: rat carcinosarcoma; endothelin-1; ETB agonist IRL 1620; ETA and ETB receptors distribution; blood flow; vascular resistance
Dates:
  • Published: 5 July 2005
  • Published (online): 21 June 2005
  • Accepted: 20 May 2005
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 11 May 2017 14:55
Last Modified: 11 May 2017 14:58
Published Version: https://doi.org/10.1038/sj.bjc.6602672
Status: Published
Publisher: Cancer Research UK
Refereed: Yes
Identification Number: https://doi.org/10.1038/sj.bjc.6602672

Share / Export

Statistics